China
· Delayed Price · Currency is CNY Walvax Biotechnology Company Description
Walvax Biotechnology Co., Ltd., researches, develops, produces, and markets vaccines in China.
The company offers SARS-CoV-2 mRNA vaccine, an immunization to prevent COVID-19 to individuals 18 years of age and older; 13-valent pneumococcal polysaccharide conjugate vaccine, an invasive diseases caused by streptococcus pneumoniae for use in infants and children 6 weeks through 5 years of age; and recombinant human papillomavirus bivalent vaccine, for the prevention of cervical cancers and precancerous lesions caused by human; 23-valent pneumococcal polysaccharide vaccine, for individuals age 2 years of pneumococcal diseases; ACYW135 meningococcal polysaccharide vaccine, for the prevention of invasive meningococcal diseases; Group A and C meningococcal polysaccharide vaccine, for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium neisseria meningitidis; Group A and Group C meningococcal conjugate vaccine, for the prevention of invasive meningococcal diseases caused by Neisseria meningitidis serogroups A and C for children 3 months through 5 years of age.
It also provides haemophilus influenzae type b conjugate vaccine, for the prevention of invasive infections for children 2 months through 5 years of age; diphtheria, tetanus, and acellular pertussis combined vaccine, for diphtheria and tetanus for infants and children 3 months through 6 years of age.
Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.
| Country | China |
| Founded | 2001 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,388 |
| CEO | Runsheng Jiang |
Contact Details
Address: No. 395 Kexin Road Kunming, Yunnan Province 650101 China | |
| Phone | 86 87 1683 30860 |
| Website | walvax.com |
Stock Details
| Ticker Symbol | 300142 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000WN2 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Runsheng Jiang | Director and President |
| Hua Zhou | Chief Financial Officer |
| Yun Yan Wu | Director of Operations |
| Jin Long Zhao | Chief Investment Officer |
| Lin Yuan | Technical Director |
| Wei Yao | Marketing Director |
| Qing Gongsun | Director of Human Resources |
| Jiankang Zhang | Vice President and Director |
| Shao Zhong Dong | Vice President and Director |
| Yu Ran Liu | Board Secretary |